-37,

Yafei Qin1, Bo Shao2, Shao-Hua Ren2

  • 1Department of General Surgery, Tianjin Medical University General Hospital, Tianjin, PR China; Department of Vascular Surgery, Zhengzhou University People's Hospital, Henan Provincial People's Hospital, Zhengzhou, PR China.

Cytotherapy
|December 30, 2023
PubMed
概括

介质素-37 (IL-37) 对子宫内膜再生细胞 (ERC) 是必不可少的,以预防移植后的慢性异位血管病变 (CAV). 这项研究表明,IL-37调解了ERCs的免疫调节作用,改善了长期的全移植接受度.